Clinical recommendations for predictive risk assessment aim to reduce the incidence of severe hyperbilirubinemia and bilirubin encephalopathies while minimizing the risks of unintended harm such ...

However, because babesiosis is associated with hemolytic anemia, the presence of unconjugated hyperbilirubinemia would be expected. Tickborne rickettsial diseases, such as Rocky Mountain spotted ...

Gilbert syndrome is a genetic liver condition that causes high bilirubin levels in the blood, known as hyperbilirubinemia. Your liver makes bilirubin to help digest food. But if you have Gilbert ...

Phototherapy is effectively used for treating neonatal hyperbilirubinemia: The BiliLux phototherapy light has its irradiance peaks in the most effective wavelength range to reduce the bilirubin ...

There was history of exchange transfusion for hyperbilirubinemia via umbilical vein in two neonates with PVT. Conclusion: Catheter-associated portal venous thrombosis was uncommon in our study.

J Midwifery Womens Health. 2009;5(4):321-326. Immediate cord clamping is often included as part of active management of the third stage of labor. Although it is now well known that active ...

Gestational diabetes mellitus (GDM) is defined as sugar intolerance during pregnancy and usually occurs during the 24th to ...

In 1974, Brouet and colleagues described a classification system, which is still used today, based on the isotype (or isotypes) of immunoglobulins constituting the cryoglobulinemia: type I ...

including hyperbilirubinemia encephalopathy — a rare neurological condition in newborns with severe jaundice that can cause brain damage. They claim the failure of health-care workers to ...

Adolescent Medicine, Allergy, Anesthesia, Behavior, Bioethics/Palliative Care, Cardiology, Cardiometabolic Disorders, Clinical Research/Methodology, Controversies ...

The American Pediatric Society (APS) and the Society for Pediatric Research (SPR) are pleased to announce Cynthia F. Bearer, ...

and hyperbilirubinemia. Dose reductions occurred in 23% of patients treated with ENHERTU. The most frequent adverse reactions (>2%) associated with dose reduction were fatigue, nausea ...